SXTC实时信号 | 通过Getagraph.com最大化利润

出售 117446 min ago

@ $2.15

发出时间: 15 Feb 2024 @ 02:52

回报率: -55.32%

上一信号: Feb 14 - 22:31

上一信号: 购买

回报率: 13.46 %

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China...

Stats
今日成交量	224 228
平均成交量	1.16M
市值	10.03M
EPS	$0 ( 2023-10-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.480
ATR14	$0.00500 (0.52%)

音量相关性

長: 0.12 (neutral)

短: -0.69 (moderate negative)

Signal:(46.338) Neutral

China SXT Pharmaceuticals 相关性

10 最正相关
SIRI	0.87
LSXMA	0.856
LSXMK	0.854
CVBF	0.846
MCMJ	0.846
BMRC	0.839
TVACW	0.838
BSRR	0.838
FGBI	0.838
ESSA	0.837

10 最负相关
BLPH	-0.864
INTA	-0.861
MLTX	-0.846
MNDY	-0.838
FSLR	-0.838
LRMR	-0.83
DUOL	-0.828
RIVE	-0.828
DSEY	-0.828
PLYA	-0.824

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

China SXT Pharmaceuticals 相关性 - 货币/商品

-0.25
( neutral )

-0.56
( weak negative )

0.00
( neutral )

-0.69
( moderate negative )

China SXT Pharmaceuticals 财务报表

Annual	2023
营收:	$1.97M
毛利润:	$426 271 (21.62 %)
EPS:	$-5.71

FY	2023
营收:	$1.97M
毛利润:	$426 271 (21.62 %)
EPS:	$-5.71

FY	2022
营收:	$2.60M
毛利润:	$1.25M (48.10 %)
EPS:	$-5.52

FY	2021
营收:	$4.78M
毛利润:	$2.84M (59.43 %)
EPS:	$-0.191

Financial Reports:

No articles found.

China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.